Planet Labs PBC (NYSE:PL) Trading Down 4.5% – Should You Sell?

Planet Labs PBC (NYSE:PL) shares were down 4.5% on Friday . The stock traded as low as $30.54 and last traded at $30.9330. Approximately 16,052,008 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 13,757,243 shares. The stock had previously closed at $32.40.

Trending Headlines about Planet Labs PBC

Here are the key news stories impacting Planet Labs PBC this week:

• Positive Sentiment: Planet is expanding production in Berlin to meet rising European AI satellite demand, which should accelerate revenue growth and shorten delivery lead times for European customers. Planet Labs Expands Berlin Production To Serve European AI Satellite Demand
• Positive Sentiment: The company announced redemption of its outstanding public warrants — a move that typically removes a potential long-term dilution overhang and simplifies the capital structure, which investors generally view favorably. Planet Labs Announces Redemption of Outstanding Public Warrants
• Positive Sentiment: Multiple analyst upgrades — including bullish notes and a Morgan Stanley call — have driven fresh buying interest and helped lift PL to 1‑year/all‑time highs, signaling increased Wall Street attention. Planet Labs PBC (NYSE:PL) Trading Up 13.4% Following Analyst Upgrade
• Positive Sentiment: Coverage and investor interest are rising after a strong performance year (major share gains and reported profitability momentum), attracting retail and institutional flows. Planet Labs Stock Has Risen 765% in a Year and Wall Street Is Just Now Paying Attention
• Neutral Sentiment: Brokerage consensus remains around a “Hold” on average, indicating mixed sentiment among analysts despite recent upgrades — investors should watch next formal research notes for conviction. Planet Labs PBC (NYSE:PL) Given Average Recommendation of “Hold” by Brokerages
• Neutral Sentiment: Several newsmakers (press releases and trade press) simply restate corporate actions (warrant redemption) or expansion plans — important but contingent on execution timelines. Planet Announces Redemption of Public Warrants
• Negative Sentiment: The stock’s rapid rally increases the risk of short-term volatility and profit‑taking; a large run-up means disappointment on execution or macro weakness could trigger outsized declines. Planet Labs Stock Has Risen 765% in a Year and Wall Street Is Just Now Paying Attention
• Negative Sentiment: Broader market pullback and macro uncertainty this week put pressure on high‑beta, growth‑oriented names like PL, which can temper near‑term gains even when company‑specific news is positive. MarketBeat Week in Review – 03/23 – 03/27

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on PL shares. Craig Hallum reissued a “buy” rating and set a $30.00 price objective on shares of Planet Labs PBC in a research report on Tuesday, January 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Planet Labs PBC in a research note on Thursday, January 22nd. The Goldman Sachs Group reiterated a “neutral” rating and issued a $16.40 price target on shares of Planet Labs PBC in a report on Tuesday, January 20th. Citigroup raised their price objective on Planet Labs PBC from $19.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Planet Labs PBC from $16.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Six investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $27.25.

Planet Labs PBC Trading Down 4.5%

The company has a quick ratio of 1.64, a current ratio of 1.65 and a debt-to-equity ratio of 2.37. The firm’s 50-day moving average price is $25.71 and its 200 day moving average price is $18.58. The company has a market capitalization of $9.70 billion, a P/E ratio of -39.66 and a beta of 1.95.

Planet Labs PBC (NYSE:PL) last announced its quarterly earnings results on Thursday, March 19th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.43). The business had revenue of $86.82 million during the quarter, compared to the consensus estimate of $78.17 million. Planet Labs PBC had a negative net margin of 80.22% and a negative return on equity of 69.61%. The firm’s revenue for the quarter was up 41.1% on a year-over-year basis. As a group, equities research analysts predict that Planet Labs PBC will post -0.37 earnings per share for the current year.

Insider Activity

In other Planet Labs PBC news, Director Kristen Robinson sold 47,835 shares of the firm’s stock in a transaction on Wednesday, January 21st. The stock was sold at an average price of $26.96, for a total transaction of $1,289,631.60. Following the transaction, the director directly owned 222,897 shares in the company, valued at approximately $6,009,303.12. This trade represents a 17.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ashley F. Johnson sold 150,731 shares of Planet Labs PBC stock in a transaction on Wednesday, January 21st. The stock was sold at an average price of $27.01, for a total transaction of $4,071,244.31. Following the transaction, the chief financial officer directly owned 1,956,101 shares in the company, valued at $52,834,288.01. This represents a 7.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 218,566 shares of company stock worth $5,896,276 over the last 90 days. 17.53% of the stock is currently owned by corporate insiders.

Institutional Trading of Planet Labs PBC

Several institutional investors and hedge funds have recently made changes to their positions in the company. New York State Common Retirement Fund grew its holdings in shares of Planet Labs PBC by 45.3% in the third quarter. New York State Common Retirement Fund now owns 202,384 shares of the company’s stock valued at $2,627,000 after acquiring an additional 63,088 shares in the last quarter. Divisadero Street Capital Management LP bought a new position in Planet Labs PBC in the 3rd quarter valued at $13,564,000. Oppenheimer & Co. Inc. grew its stake in Planet Labs PBC by 74.1% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 2,002,184 shares of the company’s stock valued at $25,988,000 after purchasing an additional 851,937 shares during the period. Ranger Investment Management L.P. purchased a new stake in shares of Planet Labs PBC during the 3rd quarter valued at $2,688,000. Finally, Rice Hall James & Associates LLC bought a new stake in shares of Planet Labs PBC during the 3rd quarter worth $4,392,000. Hedge funds and other institutional investors own 41.71% of the company’s stock.

About Planet Labs PBC

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.